We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Era for Millions with Osteoarthritis in the UK

By HospiMedica staff writers
Posted on 13 Mar 2008
New guidelines issued in the United Kingdom (UK) suffering from osteoarthritis (OA) stipulate that age, obesity, gender, smoking, or people's other illnesses should not dissuade doctors from referring them for joint replacement surgery where this is clinically appropriate.

The new guidelines issued by the U.K. More...
National Institute of Health and Clinical Excellence (NICE, London, UK) recommend that OA patients needing National Health Service (NHS; London, UK) joint surgery are referred promptly when other treatments have failed them. Breaking with a past in which people were often kept waiting until their joints had worn out, the new NICE guidelines for England and Wales recommend action before people experience severe pain or prolonged loss of function. This may include consideration for surgery once osteoarthritis starts having a 'substantial impact' on quality of life. The NICE guidelines also set out a package for the holistic assessment and active management of OA, recommending a whole-person prescription which may include exercise, weight management, pain relieving gels and medications, and provision by health professionals of information to help people understand their OA and the control of its symptoms.

"It's fantastic news for people with OA. Surgery may be the kindest cut when other treatments have failed, especially as modern techniques mean you needn't wait to lose a joint to save it,” said Mr. Neil Betteridge, chief executive of Arthritis Care (London, UK). "The clarity of these guidelines should bring some much-needed consistency.”

"It recommends the holistic and can-do approach that Arthritis Care has always promoted. The package means that people should never again be told that ‘nothing can be done', that ‘osteoarthritis is a natural part of getting old', and something you ‘just have to put up with',” added Mr. Betteridge.

Arthritis is the UK's biggest single cause of physical disability, affecting around nine million Britons of all ages. Symptoms include pain and stiffness in the joints, often resulting in sleeplessness, fatigue, and depression. Mobility and ability to work may be compromised. With a plummeting income, involvement in sport and social life can diminish, leading to isolation, depression, and a loss of self-esteem.


Related Links:
U.K. National Institute of Health and Clinical Excellence
National Health Service
Arthritis Care

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.